Description
Selank is a synthetic heptapeptide derived from the endogenous tetrapeptide tuftsin (threonyl-lysyl-prolyl-arginine), with an added Gly-Pro sequence to enhance metabolic stability. Developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, Selank has been investigated in preclinical and clinical research for its immunomodulatory and anxiolytic properties. Published studies have explored its effects on BDNF expression, monoamine neurotransmitter metabolism, IL-6 modulation, and enkephalin system interactions. This 5mg lyophilized preparation is intended strictly for in vitro research and laboratory investigation. Not for human consumption.
